According to our in situ hybridization data, CD86 was constantly expressed by CCH tumor cells independent of tumor area or stage of regression, which was recently confirmed on the protein level (Diehl & Hansmann, 2024). Here, CD86 is linked to columnar cell hyperplasia of the breast.